China Tracker - Details for Winner Medical Group (WWIN)

 Winner Medical Group
Shares Outstanding (MRQ): 24.06 mill
New Shares / Dilution (TTM): 1.70 mill7.59%
New Shares / Dilution (since Dec 31, 2008): 1.64 mill7.33% 
Cash (MRQ): 12.74 mill0.00%
Account Receivables (MRQ): 15.96 mill0.00%
Account Receivables (Q/Q): + 3.48 mill  
Long-Term Debt (MRQ): NO DEBT
Revenue Growth (Q/Q): 18.61% 
Revenue Growth (Y/Y): 26.97% 
Net Income Growth (Q/Q): 26.06% 
Net Income Growth (Y/Y): 10.13% 
EPS Growth (Y/Y): 2.36% 
Net Margin (Q/Q): 10.9% (10.3%)0.60% 
Net Margin (Y/Y): 10.9% (12.6%)-1.70% 
EPS | P/E (2 MRQ Projection): $0.500.00 
CFPS | P/CF (2 MRQ Projection): $0.200.00 
Price/Sales (2 MRQ Projection): 0.00
Price/Book (MRQ): 0.00 
Auditor: BDO Limited
 
 Forward Projections (Fiscal Year)
EPS | P/E (Estimates updated 2010-10-31): $0.580.00 
 Basic Facts and History (show more)
Reporting Type: U.S. Company (10-K Filings) 
Going Public: Reverse Merger on 2005-12-16 
Uplisting to Senior Exchange: on 2009-10-08 at $4.40 (-100.00% since Uplisting)

 Business Outlook

Winner Medical reaffirms its total revenues in fiscal year 2011 to be in the range of $138 million to $150 million, representing a 20-30% year-over-year increase.

(Source: PR Newswire, 2011-05-11)

Winner Medical reaffirms its total revenues in fiscal year 2011 to be in the range of $138 million to $150 million, representing a 20-30% year-over-year increase. "During the first quarter of fiscal year 2011, cotton prices continued to increase and these raw material price increases were shifted to our customers. Early in the quarter, some customers chose to delay purchases and reduced their inventory while monitoring cotton price trends. Starting in November, having depleted the majority of their inventory, our customers increased their purchases again, resulting in December sales being one of the strongest months that Winner Medical has recorded in recent years. I believe the medical dressings and medical disposables markets have now largely accepted the cotton price increases from last year and we expect positive margin and sales growth for the remainder of 2011."

(Source: PR Newswire, 2011-02-10)

Winner Medical expects its total revenues in fiscal year 2011 to be in the range of $138 million to $150 million, representing a 20-30% year-over-year increase. This forecast reflects Winner Medical's current and preliminary view, which is subject to change. "During the past year we have made significant progress on several of our growth initiatives which are evidenced in our full year results, which include stable gross margins. We are confident the actions we have taken will yield further operating benefits during 2011. Our brand and competitive position continues to improve as rising commodity costs drive smaller competitors out of business. As we raise prices and gain additional market share by expanding distribution in China and abroad, we are confident in achieving our revenue growth to our target rate of 20%-30% per annum."

(Source: PR Newswire, 2010-11-12)

    see all Business Outlook notes


Warning: Division by zero in /home/fixyou/public_html/tracker_details.php on line 652
 Analyst Coverage (show more)
2011-08-11Roth CapitalReiterationBuy$7.00
2011-08-08Roth CapitalReiterationBuy$7.00
2011-05-12Roth CapitalReiterationBuy$6.80
2011-03-28Roth CapitalReiterationBuy$7.30
2011-02-11Brean MurrayReiterationBuy$9.00

WWIN is currently followed by 4 analysts. All 4 give the stock a positive rating. The average price target is 9.00.


    see all Analyst Ratings

 Recent Financings
2010-04-27Priced$8.42 mill1.38 mill shares$6.10

 Investor Presentations
2010-03-01 (PDF)   DOWNLOAD (right click, save as)
WWIN
Healthcare & Drugs
SCORE
3
READ: Score Cards Explained
Current Price:  n/a
F10k Day (2007-09-06): -100.00%$3.90
2009 Close: -100.00%$7.38
2010 Close: -100.00%$5.50
2011 Close: -100.00%$2.58
High (2012-10-16): -100.00%$4.47
Low (2012-06-07): -100.00%$3.20
Exchange: PNK
Market Capitalization: n/a
Total Shares: 24.06 mill
Float: n/a
Avg Volume: 28.80 k
Short Interest: 129.50 k
Short Ratio: 2.25%4.5 d
Last Quarter: 2010-06-30
Revenue (MRQ): 30.93 mill
Net Income (MRQ): 3.37 mill
Op. Cash Flow (MRQ): -2.01 mill
all financial data provided without warranty